Nanoparticle-protein interactions: From crucial plasma proteins to key enzymes

Journal of Physics: Conference Series

Volumn 304, Issue 1, 2011, Pages

  Sanfins, Elodie ^a   Dairou, Julien ^a   Rodrigues Lima, Fernando ^a   Dupret, Jean Marie ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYMES;

BIOLOGICAL FUNCTIONS; ENZYMATIC ACTIVITIES; KEY ENZYMES; PLASMA PROTEIN; POTENTIAL EFFECTS; PROTEIN INTERACTION;

PROTEINS;

EID: 80052076779     PISSN: 17426588     EISSN: 17426596     Source Type: Conference Proceeding    
DOI: 10.1088/1742-6596/304/1/012039     Document Type: Conference Paper

References (28)

1. Cedervall T et al 2007 Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles Proceedings of the National Academy of Sci. of the United States America 104 (7) 2050-2055 Fév.
2. Dutta D et al 2007 Adsorbed Proteins Influence the Biological Activity and Molecular Targeting of Nanomaterials Toxicological Sci. 100 (1) 303-315
3. Deng Z J, Mortimer G, Schiller T, Musumeci A, Martin D and Minchin R F 2009 Differential plasma protein binding to metal oxide nanoparticles Nanotechnology 20 (45) 455101
4. Xia X, Monteiro-Riviere N A and Riviere J E 2010 An index for characterization of nanomaterials in biological systems Nature Nanotechnology 5 (9) 671-675 Sep.
5. Dell'Orco D, Lundqvist M, Oslakovic C, Cedervall T and Linse S 2010 Modeling the Time Evolution of the Nanoparticle-Protein Corona in a Body Fluid PLoS ONE 5 (6) e10949 Juin
6. Göppert T M and Müller R H 2005 Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting Int. J. Pharmaceutics 302 (1) 172-186
7. The Vroman Effect - Proteins at Interfaces II - ACS Symposium Series (ACS Publications) [Online]. Available: http://pubs.acs.org.gate1.inist.fr/doi/abs/ 10.1021/bk-1995-0602.ch008. [Accessed: 25-Oct-2010]
8. Cedervall T et al 2007 Detailed Identification of Plasma Proteins Adsorbed on Copolymer Nanoparticles Angewandte Chemie Int. edn 46 (30) 5754-5756
9. Lindman S, Lynch I, Thulin E, Nilsson H, Dawson K A and Linse S 2007 Systematic Investigation of the Thermodynamics of HSA Adsorption to N-iso-Propylacrylamide/N-tert-Butylacrylamide Copolymer Nanoparticles. Effects of Particle Size and Hydrophobicity Nano Lett. 7 (4) 914-920 Avr.
10. Nel A E et al 2009 Understanding biophysicochemical interactions at the nano-bio interface Nat Mater 8 (7) 543-557 Juil
11. Chandra G, Ghosh K S, Dasgupta S and Roy A 2010 Evidence of conformational changes in adsorbed lysozyme molecule on silver colloids Int. J. Biological Macromolecules 47 (3) 361-365 Oct.
12. Chakraborti S et al 2010 Structure and activity of lysozyme on binding to ZnO nanoparticles Langmuir: The ACS J. Surfaces Colloids 26 (5) 3506-3513 Mar.
13. 2 with lysozyme: insights into the enzyme toxicity of nanosized particles Environmental Sci. Pollution Research 17 (3) 798-806
14. Wu Y, He F, He X, Li W and Zhang Y 2008 Spectroscopic studies on the interaction between CdTe nanoparticles and lysozyme Spectrochimica Acta Part A: Molecular Biomolecular Spectroscopy 71 (4) 1199-1203 Déc
15. Asuri P, Bale S S, Pangule R C, Shah D A, Kane R S and Dordick J S 2007 Structure, Function, and Stability of Enzymes Covalently Attached to Single-Walled Carbon Nanotubes Langmuir 23 (24) 12318-12321 Nov.
16. Asuri P, Bale S S, Pangule R C, Shah D A, Kane R S and Dordick J S 2007 Structure, Function, and Stability of Enzymes Covalently Attached to Single-Walled Carbon Nanotubes Langmuir 23 (24) 12318-12321 Nov.
17. You C, Arvizo R R and Rotello V M 2006 Regulation of alpha-chymotrypsin activity on the surface of substrate-functionalized gold nanoparticles Chem. Commun. (Cambridge, England) 27 2905-2907 Juil
18. Fischer N O, McIntosh C M, Simard J M and Rotello V M 2002 Inhibition of chymotrypsin through surface binding using nanoparticle-based receptors Proceedings of the National Academy of Sci. of the United States America 99 (8) 5018-5023 Avr.
19. Zhang B, Xing Y, Li Z, Zhou H, Mu Q and Yan B 2009 Functionalized Carbon Nanotubes Specifically Bind to a-Chymotrypsin's Catalytic Site and Regulate Its Enzymatic Function Nano letters 9 (6) 2280 Juin.
20. Medina C, Santos-Martinez M J, Radomski A, Corrigan O I and Radomski M W 2007 Nanoparticles: pharmacological and toxicological significance British J. Pharmacology 150 (5) 552-558 Mar.
21. Wang Z, Zhang K, Zhao J, Liu X and Xing B 2010 Adsorption and inhibition of butyrylcholinesterase by different engineered nanoparticles Chemosphere 79 (1) 86-92 Mar.
22. Fröhlich E, Kueznik T, Samberger C, Roblegg E, Wrighton C and Pieber T R 2010 Size-dependent effects of nanoparticles on the activity of cytochrome P450 isoenzymes Toxicology Appl. Pharmacology 242 (3) 326-332 Fév.
23. Lamb J G, Hathaway L B, Munger M A, Raucy J L and Franklin M R 2010 Nano-silver Particle Effects on Drug Metabolism in Vitro Drug Metabolism and Disposition: The Biological Fate of Chemicals Sep.
24. D'Armiento J 2002 Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction Trends Cardiovascular Medicine 12 (3) 97-101 Avr.
25. Longthorne V L and Williams G T 1997 Caspase activity is required for commitment to Fas-mediated apoptosis The EMBO J. 16 (13) 3805-3812 Juil.
26. Ozbek Y K et al 2010 Combined effect of CYP1B1 codon 432 polymorphism and N-acetyltransferase 2 slow acetylator phenotypes in relation to breast cancer in the Turkish population Anticancer Research 30 (7) 2885-2889 Juil.
27. Shultz M D, Ham Y, Lee S, Davis D A, Brown C and Chmielewski J 2004 Small-molecule dimerization inhibitors of wild-type and mutant HIV protease: a focused library approach J. the American Chem. Society 126 (32) 9886-9887 Ao.
28. Singh I 1997 Biochemistry of peroxisomes in health and disease Molecular Cellular Biochemistry 167 (1) 1-29 Fév.